[go: up one dir, main page]

AU2001219236A1 - Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade - Google Patents

Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade

Info

Publication number
AU2001219236A1
AU2001219236A1 AU2001219236A AU1923601A AU2001219236A1 AU 2001219236 A1 AU2001219236 A1 AU 2001219236A1 AU 2001219236 A AU2001219236 A AU 2001219236A AU 1923601 A AU1923601 A AU 1923601A AU 2001219236 A1 AU2001219236 A1 AU 2001219236A1
Authority
AU
Australia
Prior art keywords
useful
coagulation cascade
selective inhibition
polycyclic aryl
substituted polycyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001219236A
Inventor
Darin E. Jones
Melvin L. Rueppel
Michael S. South
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2001219236A1 publication Critical patent/AU2001219236A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001219236A 2000-05-18 2000-11-20 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade Abandoned AU2001219236A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/574,207 US6458952B1 (en) 1999-05-19 2000-05-18 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US09574207 2000-05-18
PCT/US2000/031885 WO2001087852A1 (en) 2000-05-18 2000-11-20 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade

Publications (1)

Publication Number Publication Date
AU2001219236A1 true AU2001219236A1 (en) 2001-11-26

Family

ID=24295129

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001219236A Abandoned AU2001219236A1 (en) 2000-05-18 2000-11-20 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade

Country Status (3)

Country Link
US (2) US6458952B1 (en)
AU (1) AU2001219236A1 (en)
WO (1) WO2001087852A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015230B1 (en) * 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
PA8591801A1 (en) * 2002-12-31 2004-07-26 Pfizer Prod Inc BENZAMID INHIBITORS OF THE P2X7 RECEIVER.
US7214825B2 (en) 2003-10-17 2007-05-08 Honeywell International Inc. O-(3-chloropropenyl) hydroxylamine free base
KR20070115583A (en) * 2004-06-29 2007-12-06 화이자 프로덕츠 인코포레이티드 Unsubstituted 5- [4- (2-hydroxy-ethyl) -3,5-dioxo-4,5-dihydro-3H- [1,2,3-substituted at the 4-position of the triazine in the presence of a Lewis acid 4] Production method of the derivative having P2Ｘ7 inhibitory activity by reaction of triazin-2-yl] -benzamide derivative with oxirane
ES2618500T3 (en) 2006-10-20 2017-06-21 Neurendo Pharma, Llc Method to restore the incretin effect
UA112897C2 (en) 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт BICYCLIC SUBSTITUTED URATILES AND THEIR APPLICATIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES
ES2787223T3 (en) 2014-11-07 2020-10-15 Univ Minnesota Salts and compositions useful for treating diseases
CN116410143A (en) * 2021-12-29 2023-07-11 杭州奥默医药股份有限公司 A kind of multi-substituted uracil derivative and its preparation method and application

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910541A (en) * 1982-07-09 1984-01-20 Takeda Chem Ind Ltd Quinone compound
JPS60255749A (en) * 1984-05-31 1985-12-17 Univ Nagoya Quinone derivative
US5304658A (en) * 1984-08-01 1994-04-19 Takeda Chemical Industries, Ltd. Quinone derivatives, their production and use
IL81264A (en) * 1986-01-30 1990-11-05 Takeda Chemical Industries Ltd Quinone derivatives,their production and pharmaceutical compositions containing them
US5008267A (en) * 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
GB9216272D0 (en) 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
CA2133657A1 (en) 1992-04-16 1993-10-28 Peter R. Bernstein Substituted derivatives
US5441960A (en) 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
US5618792A (en) 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
DE69526677T2 (en) 1994-12-13 2002-12-05 Corvas International, Inc. AROMATIC HETEROCYCLIC DERIVATIVES AS ENZYMINHIBITORS
US5656645A (en) 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5658930A (en) 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US6011158A (en) 1994-12-13 2000-01-04 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5948785A (en) 1995-04-27 1999-09-07 The Green Cross Corporation Heterocyclic amide compounds and pharmaceutical use of the same
US5612378A (en) 1995-06-06 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
US5741819A (en) 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
JPH11508558A (en) 1995-06-27 1999-07-27 メルク エンド カンパニー インコーポレーテッド Pyridinone thrombin inhibitor
AU720616B2 (en) 1996-02-22 2000-06-08 Merck & Co., Inc. Pyridinone thrombin inhibitors
EE9800353A (en) 1996-04-23 1999-04-15 Merck & Co., Inc. Pyrazinones thrombin inhibitors
US5668289A (en) 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
AU724191B2 (en) 1996-08-29 2000-09-14 Merck & Co., Inc. Integrin antagonists
CA2263198A1 (en) 1996-09-06 1998-03-12 Nippon Kayaku Kabushiki Kaisha Novel acetamide derivatives and protease inhibitors
WO1998010763A1 (en) 1996-09-13 1998-03-19 Merck & Co., Inc. Thrombin inhibitors
US5872138A (en) 1996-09-13 1999-02-16 Merck & Co., Inc. Thrombin inhibitors
JP2001502674A (en) 1996-10-11 2001-02-27 シーオーアール・セラピューティックス・インコーポレーテッド Selective factor Xa inhibitor
CA2268381A1 (en) 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Selective factor xa inhibitors
AU715305B2 (en) 1996-10-24 2000-01-20 Merck & Co., Inc. Thrombin inhibitors
US5869487A (en) 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
CN1088706C (en) 1996-10-25 2002-08-07 卫福有限公司 Novel heterocyclic amide compound and its medical application
AU722429B2 (en) 1997-01-22 2000-08-03 Merck & Co., Inc. Thrombin inhibitors
US5792779A (en) 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
JP2001518932A (en) 1997-03-24 2001-10-16 メルク エンド カンパニー インコーポレーテッド Thrombin inhibitors
US5866573A (en) 1997-04-21 1999-02-02 Merck & Co., Inc. Pyrazinone thrombin inhibitors
IL123986A (en) 1997-04-24 2011-10-31 Organon Nv Serine protease inhibiting antithrombotic agents and pharmaceutical compositions comprising them
KR20010012174A (en) 1997-05-02 2001-02-15 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 Serine protease inhibitors
IL133621A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
ES2241151T3 (en) 1997-06-26 2005-10-16 Eli Lilly And Company ANTITROMBOTIC AGENTS.
EP0999834B1 (en) 1997-06-26 2005-10-12 Eli Lilly And Company Antithrombotic agents
CA2301520A1 (en) 1997-09-05 1999-03-11 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6037356A (en) 1997-11-26 2000-03-14 3-Dimensional Pharmaceuticals, Inc. Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
AU1605699A (en) 1997-11-26 1999-06-15 Corvas International, Inc. Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
JP2002509153A (en) 1998-01-20 2002-03-26 ワーナー−ランバート・カンパニー N- [2- (5-benzyloxycarbonyl-amino-6-oxo-2- (4-fluorophenyl) -1,6-dihydro-1-) as an in vivo inhibitor of interleukin-1β converting enzyme (ICE) Pyrimidinyl) acetoxyl] -L-aspartic aldehyde
AU753479B2 (en) 1998-05-19 2002-10-17 Merck & Co., Inc. Pyrazinone thrombin inhibitors
JP2002516326A (en) 1998-05-26 2002-06-04 メルク エンド カムパニー インコーポレーテッド Imidazopyridine thrombin inhibitors
EP1089752A4 (en) 1998-06-03 2002-01-02 Cortech Inc Alpha-keto oxadiazoles as serine protease inhibitors
EP1589029B1 (en) 1998-06-11 2010-03-17 Ortho-McNeil Pharmaceuticals, Inc. Pyrazinone protease inhibitors
DK0997474T3 (en) 1998-08-14 2004-02-09 Pfizer Antithrombotic agents
CA2343109A1 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. Thrombin inhibitors
AU747776B2 (en) 1998-10-30 2002-05-23 Merck & Co., Inc. Thrombin inhibitors
JP2002528542A (en) 1998-10-30 2002-09-03 メルク エンド カムパニー インコーポレーテッド Thrombin inhibitor
FR2786482B1 (en) 1998-11-27 2002-08-09 Synthelabo NOVEL 2-PYRIDONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
WO2000038683A1 (en) 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
JP2002544263A (en) 1999-05-19 2002-12-24 ファルマシア・コーポレイション Substituted polycyclic aryl and heteroaryl uracils as anticoagulants
NZ514875A (en) 1999-05-19 2004-10-29 Pharmacia Corp Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
PL352827A1 (en) 1999-05-19 2003-09-08 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants

Also Published As

Publication number Publication date
US6458952B1 (en) 2002-10-01
US20030023086A1 (en) 2003-01-30
WO2001087852A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
IL146244A0 (en) Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
IL146245A0 (en) Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
AU2001265141A1 (en) Multifunctional periodic cellular solids and the method of making thereof
AU2002256418A1 (en) Inhibitors of bace
AU2001238426A1 (en) Prepaints and methods of preparing paints from the prepaints
AU2862100A (en) Materials and methods for the purification of polyelectrolytes
AU2001275870A1 (en) Methods and kits for the detection of arginine compounds
AU2001243598A1 (en) Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
AU2003303926A1 (en) Ceramics and methods of making the same
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2001219236A1 (en) Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
AU2002214189A1 (en) Methods of identifying inhibitory compounds and uses thereof
AU2002367752A1 (en) Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
AU2001222501A1 (en) Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
AU2002337843A1 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2001262111A1 (en) Aryl and heteroaryl sulfonates
AU2001217827A1 (en) Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
AU2002359792A1 (en) Methods and compositions for the inhibition of viral release
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
HK1047092A (en) Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
AU2001286584A1 (en) Inhibition of protein-protein interaction
AU2002334854A1 (en) 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
AU2002360614A1 (en) Methods of inhibiting fertility
AU2002220591A1 (en) Means for the identification of compounds capable of inhibiting karap-transduced signals
AU2001283789A1 (en) Trap for the purification of drainwater